Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice

UNC Libraries(2022)10.17615/4t8n-4568Source: DataRank Database

Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice is a research paper published in UNC Libraries (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: greenTopics (34)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (28)

Rao Kalla,Mark R. Zweigart ORCID,Tomáš Cihlář ORCID,Jennifer H. Tang ORCID,Richard L. Mackman ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4225818194

National Institutes of Health

Grant: 5R01AI132178-05

Broad-spectrum antiviral GS-5734 to treat MERS-CoV and related emerging CoV

National Institutes of Health

Grant: 1F32AI152296-01A1

Defining viral and immune mechanisms of Dengue virus serotype 2 immune evasion

National Institutes of Health

Grant: 5P30CA016086-41

Cancer Center Support Grant

National Institutes of Health

Grant: 5U19AI142759-04

Antiviral Drug Discovery and Development Center (AD3C)

National Institutes of Health

Grant: 5T32AI007151-42

Infectious Disease Pathogenesis Research Training Program

FWCI

0.00

Citation Percentile

0.0%

greenLicense: http://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

repositoryhttps://doi.org/10.17615/4t8n-4568

https://doi.org/10.1126/scitranslmed.abm3410

https://dx.doi.org/10.17615/4t8n-4568

https://pubmed.ncbi.nlm.nih.gov/35315683

http://dx.doi.org/10.1126/scitranslmed.abm3410

Fields of Study

RNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 ResearchAdvanced biosensing and bioanalysis techniques0301 basic medicine03 medical and health sciences

Keywords

ProdrugPathogenesisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVirologyPharmacologyNucleosideImmunologyBiologyInternal medicineGeneticsInfectious disease (medical specialty)DiseaseParentsAdenosineAlanineSARS-CoV-2NucleosidesAntiviral AgentsAdenosine MonophosphateCOVID-19 Drug TreatmentMiceAnimalsHumansProdrugsCoronavirus InfectionsResearch Articles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being